Concomitant antihistamine administration is associated with improved survival outcomes in patients with locally advanced or metastatic urothelial carcinoma treated with atezolizumab. Analysis of individual participant data from IMvigor210 and IMvigor211

Update your browser to view ScienceDirect correctly.

Your technical details and browser version:

Request ID: 8ffb5acbbf37ed40-LAX IP: 116.62.10.13 UTC time: 2025-01-10T08:39:06+00:00 Browser: Mozilla/5.0 (X11; U; Linux x86_64; en-US; rv:1.9.1.4) Gecko/20091030 Gentoo Firefox/3.5.4

View original article

UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS

Like

分享书签

0 0 0 0 0 0 0

More from this channel

Concomitant antihistamine administration is associated with improved survival outcomes in patients with locally advanced or metastatic urothelial carcinoma treated with atezolizumab. Analysis of individual participant data from IMvigor210 and IMvigor211

留言 (0)